Yahoo Web Search

Search results

1. • 

     Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 14%

     Simply Wall St. via Yahoo Finance· 1 year ago

     Editas Medicine, Inc. (NASDAQ:EDIT) shareholders will have a reason to smile today, with the...

2. • 

     Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 71%

     Simply Wall St. via Yahoo Finance· 2 weeks ago

     Key Insights Significantly high institutional ownership implies Editas Medicine's stock price is...

3. • 

     Editas Medicine, Inc. (NASDAQ:EDIT) is largely controlled by institutional shareholders who own 74%...

     Simply Wall St. via Yahoo Finance· 1 year ago

     Every investor in Editas Medicine, Inc. (NASDAQ:EDIT) should be aware of the most powerful...

4. • 

     Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three...

     Simply Wall St. via Yahoo Finance· 4 months ago

     Editas Medicine, Inc. (NASDAQ:EDIT) shareholders should be happy to see the share price up 24% in...

5. • 

     The past three years for Editas Medicine (NASDAQ:EDIT) investors has not been profitable

     Simply Wall St. via Yahoo Finance· 10 months ago

     Editas Medicine, Inc. (NASDAQ:EDIT) shareholders should be happy to see the share price up 10% in...

6. • 

     These Analysts Think Editas Medicine, Inc.'s (NASDAQ:EDIT) Sales Are Under Threat

     Simply Wall St. via Yahoo Finance· 2 years ago

     Today is shaping up negative for Editas Medicine, Inc. (NASDAQ:EDIT) shareholders, with the analysts...

7. • 

     Are Institutions Heavily Invested In Editas Medicine, Inc.'s (NASDAQ:EDIT) Shares?

     Simply Wall St. via Yahoo Finance· 2 years ago

     If you want to know who really controls Editas Medicine, Inc. (NASDAQ:EDIT), then you'll have to...

8. • 

     Strong week for Editas Medicine (NASDAQ:EDIT) shareholders doesn't alleviate pain of five-year loss

     Simply Wall St. via Yahoo Finance· 1 year ago

     Over the last month the Editas Medicine, Inc. (NASDAQ:EDIT) has been much stronger than before,...

9. • 

     Is Editas Medicine (NASDAQ:EDIT) In A Good Position To Invest In Growth?

     Simply Wall St. via Yahoo Finance· 1 year ago

     We can readily understand why investors are attracted to unprofitable companies. For example,...

10. • 

      3 No-Brainer Stocks to Buy Right Now for Less Than $25

      Motley Fool· 1 year ago

      In stock investing, it's easy to focus on big names and blue-chip companies since they are...